Skip to main content

Table 2 Comparison of DLCT quantitative parameters between different MSI status in training set and validation set

From: Dual-layer spectral-detector CT for predicting microsatellite instability status and prognosis in locally advanced gastric cancer

Parameters

Training set (n = 184)

Validation set (n = 80)

MSI-H (n = 51)

MSI-L/MSS (n = 133)

p value*

MSI-H (n = 51)

MSI-L/MSS (n = 133)

p value*

Arterial phase

 CT40keV_AP, HU

120.07 (95.50, 150.99)

126.87 (109.36, 150.24)

0.290

115.49 (87.77, 152.19)

120.01 (86.74, 150.50)

0.950

 CT70keV_AP, HU

65.98 (55.98, 76.40)

66.19 (59.07, 78.82)

0.698

63.43 (55.15, 74.65)

64.24 (51.33, 76.52)

0.968

 IDAP, mg/ml

0.96 (0.70, 1.32)

0.99 (0.79, 1.42)

0.287

0.87 (0.74, 1.17)

0.91 (0.64, 1.27)

0.928

 NIDAP

0.10 (0.08, 0.14)

0.11 (0.08, 0.16)

0.517

0.09 (0.06, 0.11)

0.10 (0.08, 0.13)

0.173

 ZeffAP

7.81 (7.67, 7.90)

7.83 (7.69, 8.03)

0.394

7.80 (7.65, 7.95)

7.80 (7.65, 8.03)

0.991

 λHUVP

1.37 (1.02, 1.55)

1.39 (1.06, 2.02)

0.340

1.21 (0.68, 1.42)

1.25 (0.85, 1.82)

0.494

Venous phase

 CT40keV_VP, HU

145.38 (124.25, 193.55)

167.37 (145.80, 198.73)

0.012

144.96 (130.04, 173.92)

177.77 (150.14, 197.73)

0.006

 CT70keV_VP, HU

79.20 (69.59, 90.48)

85.70 (73.49, 97.48)

0.035

73.82 (66.78, 85.00)

84.60 (74.21, 98.86)

0.026

 ID VP, mg/ml

1.11 (0.98, 1.42)

1.52 (1.34, 1.87)

 < 0.001

1.21 (0.98, 1.38)

1.56 (1.39, 1.99)

 < 0.001

 NIDVP

0.26 (0.20, 0.29)

0.34 (0.28, 0.41)

 < 0.001

0.23 (0.18, 0.29)

0.34 (0.28, 0.40)

 < 0.001

 ZeffVP

7.87 (7.81, 7.99)

8.13 (8.05, 8.27)

 < 0.001

7.83 (7.75, 7.95)

8.15 (8.07, 8.35)

 < 0.001

 λHUVP

1.31 (0.90, 1.81)

2.19 (1.78, 2.92)

 < 0.001

1.50 (1.18, 2.98)

2.30 (1.82, 2.97)

0.002

  1. Data are given as median (inter-quartile ranges)
  2. AP Arterial phase, DLCT Dual-layer spectral detector CT, ID Iodine density, λHU The slope of the spectral curve, MSI Microsatellite instability, MSI-H Microsatellite instability high, MSI-L/MSS Microsatellite instability low or microsatellite stable, NID Normalized iodine density, VP Venous phase, Zeff Effective atomic number
  3. *p value represents comparison between MSI-H group and MSI-L/MSS group